- Skin toxicity of BRAF and MEK inhibitors2021 | First Faculty of Medicine
- Patient with lung metastases of malignant melanoma who have long-term survival in combination therapy BRAF and MEK inhibitors2019 | First Faculty of Medicine
- Effect of target therapy with BRAF and MEK inhibitors on the immune system in metastatic melanoma2023 | First Faculty of Medicine
- Research Report University Hospital for clinical assessment BRF 115532Publication without faculty affiliation
- The Role of BRAF/MEK Inhibition in Metastatic Malignant Melanoma - a Case Study2016 | Faculty of Medicine in Hradec Králové
- Generalizovaný maligní melanom léčený kombinací BRAF a MEK inhibitorů ve 3. linii terapie2023 | First Faculty of Medicine
- The Significance of BRAFV600E Mutation in Thyroid Cancer in Terms of Novel Targeted Therapies - Overview of Current Knowledge and Studies2018 | Faculty of Medicine in Hradec Králové
- Mechanisms of resistance in malignant melanoma treated by targeted therapy2020 | First Faculty of Medicine
- Neurofibromatosis von Recklinghausen type I (NF1) - clinical picture in childhood, diagnosis and therapy2023 | Second Faculty of Medicine
- Adjuvantní terapie melanomu v přehledu2021 | First Faculty of Medicine
- Trametinib2016 | First Faculty of Medicine
- Adverse Effects of Modern Treatment of Malignant Melanoma and their Treatment/Management2014 | Faculty of Medicine in Hradec Králové
- Kudy v léčbě metastatického maligního melanomu2016 | Publication without faculty affiliation
- Biologická léčba melanomu2016 | Publication without faculty affiliation
- Research Report University Hospital for clinical assessment GO28141Publication without faculty affiliation
- Complete therapeutic response to anti-PD1 therapy in patient with advanced melanoma and resistance to targeted therapy of BRAF inhibitors2018 | First Faculty of Medicine
- Melanom - současné a budoucí trendy léčby2017 | Publication without faculty affiliation
- A long-term survivor female patient with metastatic melanoma after treatment with pembrolizumab in the third line2020 | First Faculty of Medicine
- Dabrafenib: využití v léčbě BRAF pozitivních metastazujících melanomů2014 | Publication without faculty affiliation
- Nová éra v adjuvantní léčbě pokročilého melanomu2019 | First Faculty of Medicine
- Léčba melanomu kombinací přípravků Tafinlar a Mekinist2015 | First Faculty of Medicine
- Možnosti léčby metastazujícího melanomu v kazuistikách2017 | Publication without faculty affiliation
- Complex treatment of melanoma2019 | First Faculty of Medicine
- Progress in the treatment of cerebral metastases in advanced melanoma2018 | Publication without faculty affiliation